Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of Hypoglycemia

Type 1 Diabetes Clinical Trial

— Hypo-Sense  

Official title:

Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense Sensor as a Tool for Detection of Hypoglycemia - Exploratory Study for Prototype Rev 1

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02225379
• Other study ID #: 029514ctil
• Status: Completed
• Phase: N/A
• First received: July 29, 2014
• Last updated: January 10, 2017
• Start date: September 2014
• Est. completion date: July 2016

Study information

• Verified date: January 2017
• Source: Rabin Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Hypo Sense is a non- invasive method for detection of hypoglycemia. The Hypo Sense combines an array of non-invasive sensors which monitors the patient's physiological parameters (heart & respiration rate, perspiration, skin temperature and arm motion) designed as a wrist watch device.

The Hypo sense is intended for monitoring symptoms of hypoglycemia in diabetic patients in hospital environment among type 1 and type 2 diabetes adults as an adjunctive device to reference methods

The proposed study will be consisting of two main segments:

The primary aim of segment 1 of the study is data collection and calibration of the Hypo Sense sensor prototype compared to standard invasive reference glucometer.

The primary aim of segment 2 of the study is to validate the Hypo Sense prototype performance in detecting hypoglycemic events.

During the first segment of the study we intend to collect in parallel measurements of blood glucose using reference method (capillary glucometer) and continuous data generated by the non- invasive study device during approximately 4 hours, in which a hypoglycemic event will be induced.

The reference and study device data will be analyzed using multivariate regression model to formulate a calibration algorithm model. This model will translate the set of the physiological recorded parameters into detection of hypoglycemic events.

During the second segment of the study we intend to evaluate the validity of the Hypo Sense sensor ability to detect hypoglycemic events compared to standard invasive reference method (capillary glucometer).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3
• Est. completion date: July 2016
• Est. primary completion date: July 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Signing an inform consent form prior to any trial related procedure

• Type 1 diabetes diagnosed at least 12 months prior to study inclusion

• Age > 18 years old

Exclusion Criteria:

• Participating in other device or drug study

• Any significant disease or condition, including psychiatric disorders that in the opinion of the investigator is likely to affect patient's compliance or ability to complete the study

• Patients with one or more of the following diseases: malignancy, myocardial insufficiency, nephrologic disease or any other chronic disease

• Chronic skin problem in the lower inner arm

• Pregnant or breast feeding women

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 1
• Hypoglycemia
• Nocturnal Hypoglycemia
• Type 1 Diabetes

Intervention

Device:
• Hypo-Sense (non invasive sensor)
Parallel measurements of capillary blood glucose using reference methods (both capillary glucometer and continuous sensor) and data generated by the non- invasive study device during approximately 4 hours, in which a hypoglycemic event will be induced.

Locations

Country	Name	City	State
Israel	Schneider Children's Medical Center	Petah-Tikva

Sponsors (2)

Lead Sponsor	Collaborator
Rabin Medical Center	Night Sense Ltd

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sensitivity	Sensitivity of the Hypo Sense-the proportion of hypoglycemia events detected by the Hypo Sense sensor from total number of hypoglycemic events detected by reference capillary glucometer	At final visit ( week 4 for participants at segment 1 of the study and week 6 for participants at segment 2 of the study)	No
Primary	Positive Predictive Value of the hypo-Sense	Positive Predictive Value of the hypo sense- the proportion of validated ("true") hypoglycemia events detected by the hypo sense sensor from total alerts detected by the Hypo-Sense sensor	At final visit ( week 4 for participants at segment 1 of the study and week 6 for participants at segment 2 of the study)	No